
BioSpace All NewsPublished
Cyclic peptides open new drug frontiers, if manufacturing can keep up
Cyclic peptides are gaining momentum as a drug modality, but manufacturing limitations are hindering progress.
Open originalChronological updates on AI in medicine, biotech, drug discovery, clinical trials, genomics, and biomedical research.

Cyclic peptides are gaining momentum as a drug modality, but manufacturing limitations are hindering progress.
Open original
The handheld catheterization device AI-GUIDE promises improved health outcomes for injured individuals.
Open original